IRIS PubliCatt

Innocenti, Idanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.734
EU - Europa 2.163
AS - Asia 694
AF - Africa 28
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.716
SE - Svezia 602
CN - Cina 439
IT - Italia 401
DE - Germania 373
IE - Irlanda 175
FR - Francia 140
UA - Ucraina 133
SG - Singapore 128
GB - Regno Unito 81
RU - Federazione Russa 71
FI - Finlandia 57
IN - India 54
PL - Polonia 53
CI - Costa d'Avorio 26
TR - Turchia 20
CA - Canada 14
JP - Giappone 14
BE - Belgio 13
HK - Hong Kong 13
CZ - Repubblica Ceca 10
ES - Italia 10
IR - Iran 9
NL - Olanda 9
AT - Austria 8
VN - Vietnam 5
BR - Brasile 4
CH - Svizzera 4
GR - Grecia 4
HU - Ungheria 4
KR - Corea 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
IL - Israele 3
RO - Romania 3
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
HR - Croazia 2
PK - Pakistan 2
PT - Portogallo 2
VE - Venezuela 2
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
EC - Ecuador 1
EU - Europa 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
PH - Filippine 1
SI - Slovenia 1
Totale 5.637
Salva come PNG Salva come JPEG
Città #
Chandler 666
Ashburn 204
Dublin 172
Dearborn 112
San Mateo 103
Jacksonville 101
Wilmington 95
Beijing 94
Ann Arbor 93
Singapore 76
Cattolica 74
Nanjing 73
Rome 70
Boston 63
New York 62
Princeton 61
Marseille 60
Florence 59
Milan 56
Fairfield 55
Warsaw 53
Moscow 50
Woodbridge 49
Houston 46
Lancaster 44
Nanchang 39
Bremen 35
Seattle 35
Lawrence 30
Munich 29
Abidjan 26
Kunming 26
Los Angeles 25
Redwood City 25
Shenyang 23
Boardman 21
Cambridge 20
Helsinki 19
Chicago 17
Redmond 17
Albany 16
Izmir 16
Minneapolis 16
Hefei 15
Norwalk 15
Pune 15
Nürnberg 14
Auburn Hills 13
Brussels 13
Mountain View 13
Shanghai 13
Zhengzhou 13
Hebei 12
Tianjin 11
Washington 11
Hong Kong 10
Jiaxing 10
Changsha 9
Kyoto 9
Brno 7
Leawood 7
London 7
San Francisco 7
Augusta 6
Detroit 6
Guangzhou 6
Lanzhou 6
Phoenix 6
Toronto 6
Chengdu 5
Fremont 5
Hangzhou 5
Jinan 5
North Hollywood 5
Vancouver 5
Vienna 5
Wuhan 5
Budapest 4
Edinburgh 4
Engelhard 4
Frankfurt am Main 4
Haikou 4
Hanoi 4
Kish 4
Lappeenranta 4
Monmouth Junction 4
Pavia 4
Stockholm 4
Tappahannock 4
Amsterdam 3
Bangalore 3
Bogotá 3
Central 3
Changchun 3
Falls Church 3
Garden City 3
Jiangyin 3
Mumbai 3
Naples 3
Napoli 3
Totale 3.407
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 281
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 141
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR 135
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 134
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 112
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 110
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 108
Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. 103
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 102
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 99
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 97
Mycosis fungoides as a cause of severe obstructive sleep apnea 90
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 90
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 89
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 88
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 87
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 84
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 77
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 77
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 75
The effects of omega-3 polyunsaturated fatty acids against cancer 69
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 68
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 68
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 67
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 66
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 66
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 64
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 62
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 61
Unrelated cord blood transplantation and post-transplant cyclophosphamide 61
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 60
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 60
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 59
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 58
Unrelated cord blood transplantation and post-transplant cyclophosphamide 58
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 56
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 55
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 54
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 54
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 54
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 54
the concomitance of lymphoma and breast carcinoma in the bone 53
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 51
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 51
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation 50
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 49
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 48
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 46
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 46
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 46
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 45
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients 44
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 44
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 44
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 44
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases 43
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 43
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 42
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 42
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 42
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 42
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 42
The concomitance of lymphoma and breast carcinoma in the bone 41
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 41
Second haploidentical stem cell transplantation for primary graft failure 41
Validation of the CLL-IPI and comparison with the MDACC prognostic index: analysis of 1364 newly diagnosed patients 40
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience 40
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 39
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 39
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 39
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 39
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 39
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 39
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 39
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 38
New developments in the management of chronic lymphocytic leukemia: Role of ofatumumab 37
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 37
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 36
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 36
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 35
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 34
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 34
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 31
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 31
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab 30
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 28
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment 27
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 27
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 26
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 25
Combined Genetic Lesions in TP53 and CDKN2A/CDKN2B Drive B Cell Receptor-Dependent/Costimulatory Signal-Independent Proliferation in Richter Syndrome 24
Richter transformation in Chronic Lymphocytic Leukemia 23
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia 23
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 22
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 22
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 21
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 20
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 20
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 19
Totale 5.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020770 0 66 82 81 67 130 81 40 35 56 84 48
2020/2021397 25 41 16 25 79 33 25 11 42 17 75 8
2021/2022768 61 27 31 38 57 14 9 116 32 40 181 162
2022/20231.861 255 250 133 263 141 239 107 139 209 42 64 19
2023/20241.004 44 268 61 62 42 144 70 34 18 43 106 112
2024/202561 50 11 0 0 0 0 0 0 0 0 0 0
Totale 5.801